Previously, we reported that atrazine (ATR) alters steroidogenesis in male Wistar rats resulting in elevated serum corticosterone (CORT), progesterone, and estrogens. The increase in CORT indicated that this chlorotriazine herbicide may alter the hypothalamic-pituitary-adrenal axis. This study characterizes the temporal changes in adrenocorticotropic hormone (ACTH), CORT, and P4 in male Wistar rats following a single dose of ATR (0, 5, 50, 100, and 200 mg/kg), simazine (SIM; 188 mg/kg), propazine (PRO; 213 mg/kg), or primary metabolites, deisopropylatrazine (DIA; 4, 10, 40, 80, and 160 mg/kg), deethylatrazine (DEA; 173 mg/kg), and diamino-s-chlorotriazine (DACT; 3.37, 33.7, 67.5, and 135 mg/kg). The maximum dose for each chemical was the molar equivalent of ATR (200 mg/kg). Significant increases in plasma ACTH were observed within 15 min, following exposure to ATR, SIM, PRO, DIA, or DEA. Dose-dependent elevations in CORT and progesterone were also observed at 15 and 30 min post-dosing with these compounds indicating an activation of adrenal steroidogenesis. Measurement of the plasma concentrations of the parent compounds and metabolites confirmed that ATR, SIM, and PRO are rapidly metabolized to DACT. Although DACT had only minimal effects on ACTH and steroid release, dosing with this metabolite resulted in plasma DACT concentrations that were 60-fold greater than that observed following an equimolar dose of ATR and eightfold greater than equimolar doses of DIA or DEA, indicating that DACT is not likely the primary inducer of ACTH release. Thus, the rapid release of ACTH and subsequent activation of adrenal steroidogenesis following a single exposure to ATR, SIM, PRO, DIA, or DEA may reflect chlorotriazine-induced changes at the level of the brain and/or pituitary.
Atrazine (ATR), a chlorotriazine herbicide, is used extensively in the United States for broadleaf and grassy weed control in corn, sorghum, sugarcane, cotton, and landscape vegetation. Biotransformation by-products of ATR, as well as the parent compound, are relatively persistent in water and mobile in soil (Seiler et al., 1992) and have been detected in surface and ground water in areas of major usage (Baker, 1998) . In the Midwestern river basins and community water supplies, levels of ATR have been detected that exceed the maximal contaminant level of 3 ppb set by the U.S. Environmental Protection Agency (Kello, 1989; Thurman et al., 1991) . The highest levels of ATR and by-products are typically observed in the Midwestern states during the seasonal months of farming, when ATR is used as a preemergent herbicide (Balu et al., 1998) .
The potential for environmental exposures to ATR and/or its biotransformation by-products has generated much concern, and numerous studies have been conducted during the past 10 years to determine the risks to human health and wildlife. Adverse effects of ATR on the reproductive system in mammals have been observed that are likely mediated through an effect on the central nervous system (Eldridge et al., , 1999 Stevens et al., 1994) . Specifically, exposure to ATR has been reported to cause alterations in neurotransmitter concentrations, inhibit the release of gonadotropin-releasing hormone (GnRH), diminish the estrogen-induced surge of luteinizing hormone (LH) and prolactin in rats (Cooper et al., 2007 (Cooper et al., , 1996 , and delay pubertal development in male and female rats (Laws et al., , 2003 Stoker et al., 2000 Stoker et al., , 2002 . Other studies indicate that ATR increases serum concentrations of estradiol and estrone (Modic, 2004; Stoker et al., 2000) as well as baseline adrenal corticosterone (CORT) in female rats and mice (Fraites et al., 2009; Pruett et al., 2003) and castrated male rats (Modic, 2004) .
The increase in serum CORT has been shown to persist following extended dosing up to 21 days in rats (Modic, 2004) and 28 days in mice (Pruett et al., 2009) .
To date, the precise cellular target responsible for the elevation of serum gonadal and adrenal steroids has not been elucidated. In vitro studies using the H295R adrenocortical carcinoma cell line indicate that the chlorotriazines, in general, can increase the synthesis of estrogens, primarily as a consequence of increased aromatase (CYP19) gene expression (Sanderson et al., 2000 (Sanderson et al., , 2001 . Similarly, Holloway et al. (2008) reported that ATR also influences aromatase activity in human granulosa cells. However, it is not known whether the previously reported changes in serum steroids observed following in vivo exposures are the result of a direct activation of steroid synthesis or the consequence of altered pituitary hormone secretion. To address this question, the current study was designed to characterize the dose response and time course for effects of ATR and its primary metabolites on pituitary and adrenal hormone secretion in male Wistar rats. Two other chlorotriazine herbicides, simazine (SIM) and propazine (PRO), were evaluated as both produce metabolites similar to that of ATR ( Fig. 1 ) and have been shown to disrupt the hypothalamicpituitary-gonadal (HPG) axis in rodents (Laws et al., 2003 
MATERIALS AND METHODS
Animals. Male Wistar rats (50-60 days old) were obtained from Charles River Laboratories (Raleigh, NC) and were maintained under controlled temperature (20°C-24°C), humidity (40-50%), and light (12-h light/12-h dark; lights on 0700 h, off 1900 EST) conditions with Purina Laboratory Rat Chow (5001, [Purina Mills, LLC, St Louis, MO] ) and water available ad libitum. Animals were ranked by body weight and placed into treatment groups such that the mean body weights ±SE for all groups were similar. Dosing solutions and procedures. ATR (2-chloro-4-ethylamino-6-isopropylamino-s-triazine, CAS 1912-24-9, purity 97.1%), simazine (SIM, CAS 122-34-9, purity 98%), deisopropylatrazine (DIA, purity 91%) and deethylatrazine (DEA, purity 95.7%) were gifts from Syngenta Crop Protection, Inc. (Greensboro, NC). Diamino-s-chlorotriazine (DACT, CAS 3397-62-4, purity 97%, ACROS A017756301) was purchased from Acros Organics, Liege, Belgium. PRO (2,4-bis (isopropylamino)-6-chloro-1,3,5-triazine; CAS 139-40-2, purity 99.8%) was a gift from Griffin LLC, Valdosta, GA. All the chemicals were administered by oral gavage in a suspension of 1% methyl cellulose/ distilled water (CAS 9004-67-5, M-7140; Sigma-Aldrich Chemical Company, St Louis, MO) in a volume of 5.0 ml dosing solution/kg body weight. To facilitate the comparison of the potency of each test chemical with that of ATR, the dose ranges for each test chemical were the molar equivalent of ATR (atrazine equimolar dose, Table 1 ) and were selected based on results reported in previous studies of ATR on female pubertal development (Laws et al., , 2003 . The doses used for the study were as follows: ATR (5, 50, 100, and 200 mg/kg), DACT (3.4, 33.7, 67.5 , and 135 mg/kg), DEA (173.4 mg/kg), DIA (4, 10, 40, 80, and 160 mg/kg), SIM (188 mg/kg), and PRO (213 mg/kg). Control animals received 1% methyl cellulose only.
Experimental design. To determine the effect of a single dose of ATR, SIM, PRO, or metabolites (DIA, DEA, and DACT), the animals were dosed (oral gavage) with the vehicle or the test chemicals at 0900 h and killed by decapitation at the designated times (5, 15, 30, 60, or 180 min after dosing). Animals were housed in an animal facility immediately adjacent to the necropsy room to limit the transfer time to within 15 s after removal from their home cage. To assure reliable measures of the pituitary-adrenal hormones, all rats were pre-dosed daily by oral gavage with 1% methyl cellulose vehicle for 1 week prior to administration of the test chemical to acclimate the animals to the dosing procedure. Previous experience has shown that such handling of the animals prior to actual exposure to the test chemical provides more consistent adrenocorticotropic hormone (ACTH) and CORT concentrations during the morning hours when the circadian fluctuation of these hormones is the lowest. Body weights were recorded daily during the pre-dosing period and on the day of dosing with the test chemical, and the dose administered was adjusted for FIG. 1. Chemical structures for ATR, PRO, SIM, and primary metabolites, DIA (deisopropylatrazine), DEA (deethylatrazine), and DACT (diamino-schlorotriazine).
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body weight recorded each day. Upon decapitation, blood was processed for serum and plasma, and aliquots were stored at À 80°C until measurement of ACTH, CORT, progesterone, and prolactin by radioimmunoassay (RIA) or for analytical chemistry analyses.
To serve as a positive control for an acute stress response, one group of animals were placed in adequately ventilated Plexiglas injection restrainers (PLAS Labs, Lansing, MI) for 15 min just prior to necropsy at 0900 h; breathing was monitored for all rats to ensure that the animals were not compressed. Serum and plasma were prepared for hormone analyses as described earlier.
Radioimmunoassays. Total serum CORT and progesterone were measured using Coat-A-Count RIA kits (Catalog reference: TKRC, TKPG) from Siemens Medical Solutions Diagnostics Los Angeles, CA. The limits of sensitivity for these assays were 5.7 and 0.02 ng/ml, respectively. Total plasma ACTH was measured using an RIA kit from MP Biomedicals (07-106102; Orangeburg, NY). Cross-reactivity of human ACTH antibody with rat ACTH was tested using serial dilutions of rat plasma with and without spikes of ACTH. Linearity of ACTH concentration was confirmed across all dilutions of rat plasma and in the presence of spiked rat plasma samples with ACTH. The limit of sensitivity for this assay was 5.7 pg/ml. Serum prolactin was measured by RIA using material supplied by the National Hormone and Peptide Program (Torrance, CA; http://www.humc.edu/ hormones) using the methods described by Goldman et al. (1986) . The following materials were used for the PRL assays, respectively: iodination preparation I-6, reference preparation RP-3, and antisera S-9. The limit of sensitivity for prolactin was 0.05 ng/ml and the intra-assay coefficients of variation was 0.9%.
Analytical chemistry. Extraction and analysis of rat plasma samples for ATR and metabolites (DEA, DIA, and DACT, Fig. 1 ) were based on methods described by Brzezicki et al. (2003) with slight modifications. The samples were homogenized to a fine powder with anhydrous sodium sulfate using mortar and pestle. After the addition of diethyl ether, an appropriate amount of internal standard deuterated atrazine (ATR-d 5 ; Cambridge Isotope Laboratories, Andover, MA) was added to each sample. The extraction, derivatization, and analytical procedures were the same as described in detail by Brzezicki et al. (2003) . The final extraction volume was adjusted to 500 ll with hexane. For calibration standards, ATR, DACT, DIA, DEA, and ATR-d 5 were derivatized individually. Known amounts of these methylated standards were combined to prepare a working stock solution. From this stock solution, calibration standard solutions at three concentrations were prepared and a known amount of ATR-d 5 was added to each calibration standard. Preliminary analysis was performed on an Agilent GC 6890 with 5973N mass selective detector (MSD) equipped with a DB-17MS analytical column (J&W Scientific, Folsom, CA) in the selected ion monitoring mode. Subsequent analysis was carried out on a Hewlett Packard 5890 with 5971A MSD. Quantification was performed using the internal standard method. Procedural blanks and spiked samples were taken throughout the entire analytical procedure for quality assurance. Procedural blanks were free of analytes, and spike recoveries were 87% for ATR and 117-128% for DACT. The method detection limit was estimated to be 4 ng/ml (ppb) for all analytes.
Statistical analyses. Data were analyzed by ANOVA using the general linear model procedure (Statistical Analysis System; SAS Institute, Inc., Cary, NC) for treatment, time, and treatment 3 time interactions. In cases where a significant treatment effect (p < 0.05) was observed, the dose-response data within each time point were further evaluated using the Dunnett multiple comparisons test where the control was compared with each dose group. Treatment means within each time point were tested for homogeneity of variance using the Bartlett test (Graph Pad Instat; Graph Pad Software, San Diego, CA), and, where heterogeneity was evident, the Welch t-test or KruskalWallis nonparametric test with Dunn's multiple comparison test was used. All data are reported as mean ± SEM (n).
RESULTS

Effects of a Single Dose of ATR, SIM, PRO, or Metabolites on ACTH, CORT, and Progesterone Concentrations
ACTH, CORT, and progesterone concentrations following a single exposure to ATR are shown in Figure 2 . ACTH values for the control animals were equal to those typically observed in the untreated cage control animals in our laboratory (Tables 2 and 3) indicating that the experimental design did not impact these measures. A dose-dependent significant increase in plasma ACTH was observed within 5 min post-dosing with ATR ( Fig. 2) . Maximal ACTH levels were observed at 15 min with 2.5-, 4.9-, and 9.6-fold increases in the 50, 100, and 200 mg/kg groups, respectively. Similarly, dose-dependent increases in serum CORT and progesterone were also observed at 15 min and remained elevated through 180 min in the three highest treatment groups with the maximal response (9-to 12-fold increases compared with control) occurring at 30 min post-dosing.
Hormone concentrations following a single dose of DACT are shown in Figure 3 . The doses for DACT (3.37, 33.7, 67.5, and 135 mg/kg) were equimolar to those used for the previous study with ATR (5, 50, 100, and 200 mg/kg). Another group, dosed with ATR (200 mg/kg), served as a replicate of the previous block of the study and enabled the direct comparison of ATR and DACT. Again, significant increases in ACTH, CORT, and progesterone were observed in the ATR-treated animals. However, while ACTH in the two DACT groups (33.7 and 134 mg/kg) was statistically different from control at 30 min, the 1.3-fold increase was substantially less than that observed in animals receiving an equimolar dose of ATR. Similarly, the CORT and progesterone responses to DACT were markedly less than that observed with ATR. For example, increases in CORT at 60 min post-dosing with 33.7, 67.5, and 135 mg/kg reached a maximum fivefold change compared with a 15-fold change in the ATR group. Figure 4 shows the hormone concentrations following treatment with doses of DIA (4, 10, 40, and 80 mg/kg) that were equimolar to ATR (5, 12.5, 50, and 100 mg/kg). As observed with ATR, dose-dependant elevations of ACTH were observed following a single dose of DIA with maximum increases of 3.9-and 3.7-fold in the 80 mg/kg group at 15 and 30 min, respectively. Parallel increases were observed in CORT following exposure to 10 mg/kg and higher doses of DIA at 15 min post-dosing and in the two highest treatment groups (40 and 80 mg/kg) at 30 min. Progesterone was significantly increased by the two highest DIA doses (40 and 80 mg/kg) at 15 and 30 min. Replicate treatment groups for ATR (100 mg/ kg) and DACT (67.5 mg/kg) confirmed results observed in earlier blocks of the study, with significant increases in ACTH, CORT, and progesterone in the ATR group and no significant changes in any of these parameters following exposure to DACT (67.5 mg/kg, Fig. 4) .
To complete the evaluation of the three major metabolites of ATR, DEA was tested at a dose equimolar to ATR 200 mg/kg at 15 min post-dosing. Significant increases in ACTH, CORT, and progesterone were observed following a single dose of DEA (173 mg/kg, Table 2 ). Two additional chlorotriazine herbicides, PRO and SIM, were tested at a single dose and time point. As shown in Figure 1 , PRO is metabolized to DEA and DACT, while SIM produces DIA and DACT. Both PRO (213 mg/kg) and SIM (188 mg/kg) caused significant increases in ACTH (1.6-fold) and CORT (3.0-fold) at 15 min postdosing. A significant increase in progesterone (3.3-fold) was also observed following a single dose of PRO.
To further evaluate the hormonal response associated with a single exposure to the chlorotriazines, results were compared with those that occur following an acute stress. A group of animals was restraint stressed for 15 min immediately prior to necropsy, and their ACTH, CORT, and prolactin hormone profile was compared to that observed in cage control, vehicle control, and ATR (200 mg/kg)-treated animals. ACTH, CORT, and prolactin are typically released during an acute stressmediated response. As expected, significant increases in ACTH, CORT, and prolactin were observed in the restraintstressed animals (Table 3) . However, while ACTH and CORT FIG. 3 . Dose and time response for ACTH, CORT, and progesterone serum hormone concentrations following a single dose of DACT. Male Wistar rats were pre-dosed with vehicle control for 1 week prior to receiving a single dose of vehicle (methyl cellulose), DACT (3.37, 33.7, 67.5, or 135 mg/kg, oral gavage), or ATR (200 mg/kg). Highest dose of DACT was equimolar to ATR (200 mg/kg). Groups of animals were killed at 5, 15, 30, and 60 min postdosing, and ACTH, CORT, and progesterone were measured by RIA. Mean ± SEM (n ¼ 10). *Significantly different from control at each time point by Kruskal-Wallis test (nonparametric ANOVA) and Dunn's multiple comparison test (p < 0.05). Mean ACTH ± SEM for controls over all time points: 64.71 ± 3.86 pg/ml, CORT: 51.81 ± 13.8 ng/ml, and progesterone: 0.51 ± 0.11 ng/ml.
FIG. 4. Dose and time response for ACTH, CORT, and progesterone concentrations following a single dose of DIA (deisopropylatrazine). Male
Wistar rats were pre-dosed with vehicle control for 1 week prior to receiving a single dose of vehicle (methyl cellulose), DIA (4, 10, 40, or 80 mg/kg), DACT (67.5 mg/kg), or ATR (100 mg/kg). Doses for DACT and the highest dose of DIA were equimolar to ATR (100 mg/kg). Groups of animals were killed at 15 and 30 min post-dosing, and ACTH, CORT, and progesterone were measured by RIA. Mean ± SEM (n ¼ 10). *Significantly different from control at each time point by Kruskal-Wallis test (nonparametric ANOVA) and Dunn's multiple comparison test (p < 0.05). Mean ACTH ± SEM for controls over all time points: 76.34 ± 4.57 pg/ml, CORT: 47.13 ± 9.02 ng/ml, and progesterone: 0.61 ± 0.10 ng/ml.
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were significantly elevated in the ATR treatment group, there was no significant change in prolactin.
Plasma Concentrations of Test Chemicals and Metabolites
Plasma concentrations of ATR and metabolites, DIA, DEA, and DACT, following a single dose of ATR are reported in Table 4 . ATR and all metabolites were detected at 5 min postdosing. ATR, detected at the lowest concentration of all metabolites (7-19 ng/ml), was not dose responsive and remained constant throughout the 180-min observation period. Plasma concentrations of DIA, DEA, and DACT increased with post-dosing time. DIA (111 ng/ml) was the most prevalent metabolite at 5 min post-dosing, but by 180 min, plasma concentrations of DACT (3136 ng/ml) were approximately double that of DIA and 10-fold greater than DEA. Neither ATR nor any of the metabolites were detected in plasma of the vehicle controls.
Plasma metabolite concentrations following a single dose of DIA, DEA, or DACT are reported in Table 5 . Uptake of DIA and DEA was rapid with each undergoing further dealkylation to produce comparable concentrations of DACT.
For example, treatment with DIA (161 mg/kg) or DEA (173 mg/kg) produced similar DACT concentrations (e.g., 2664 ng/ml [18lM] and 3061 ng/ml [21lM] for DIA and DEA, respectively) at 15 min post-dosing. Plasma concentrations of DACT in animals following a single dose of DACT were dose responsive and increased with post-dosing time. Table 6 shows a comparison of plasma concentrations at 15 min post-dosing with equimolar doses of ATR, PRO, SIM, or metabolites. Exposure to a single dose of any one of the primary metabolites resulted in much higher plasma concentrations for the respective metabolites when compared to that observed following an equimolar dose of ATR. For example, the plasma concentrations of DIA (6178 ng/ml; 33lM) and DEA (5966 ng/ml; 35.6lM) at 15 min following a single dose of either metabolite were 15.7-and 92-fold higher than observed in animals dosed with an equimolar dose of ATR. Exposure to DACT at a dose equimolar to ATR (200 mg/kg) resulted in plasma DACT concentrations that were 60-fold greater than observed when dosed with the parent compound and eightfold greater than when treated with equimolar doses of DIA and DEA. Finally, plasma concentrations of metabolites following exposure to PRO and SIM were similar in magnitude to that observed with an equimolar dose of ATR.
DISCUSSION
This study evaluated the effects of ATR, SIM, PRO, and primary metabolites on pituitary and adrenal hormone secretion in adult male rats. Data reported here support the findings by Pruett et al. (2003) and Fraites et al. (2009) that exposure to ATR causes a rapid increase in basal serum CORT concentrations. In addition, this study demonstrates that the elevated adrenal hormone secretion is in response to increased ACTH release following exposure to ATR, SIM, PRO, or their two metabolites, DIA and DEA. The rapid release of ACTH and In this study, the major metabolite of the chlorotriazines, DACT, had only minimal effects on the pituitary-adrenal axis. Thus, although it has been postulated that DACT is the active metabolite for the effects observed on the HPG axis following exposure to ATR (McMullin et al., 2004) , it is unlikely that this metabolite is the primary inducer of pituitary ACTH release given the much higher plasma concentrations of DACT compared with ATR, DIA, or DEA.
An initial concern when reviewing the data from this study was whether or not the ACTH-dependent release of CORT was due to the handling of the animals during the dosing procedure. However, the acclimation of the animals to handling and a predosing regimen prior to the actual exposure to the test chemicals provided consistently low hormone concentrations for vehicle controls throughout each block of the study. A comparison of animals dosed with methyl cellulose (vehicle control), ATR, or restraint stressed for 15 min demonstrated different hormone response patterns, indicating that the effects observed after ATR, DIA, or DEA were not simply a reflection of stress related to handling during the dosing procedure. In this study, ACTH, CORT, and prolactin were significantly elevated in the restraint-stressed animals, a hormone profile that is typically observed in response to many physiological and psychological stressors. In contrast, no differences in the concentrations of these hormones were observed in the vehicletreated and cage control animals (killed without any prior handling). Additionally, while ACTH and CORT were significantly elevated in the ATR-treated animals, there was no change in prolactin. The lack of a prolactin response following the single exposure to ATR as opposed to the 29-fold increase in prolactin that was observed in the restraint-stressed animals indicates that a differential set of cellular events may be responsible for the elevated ACTH/CORT that is not likely 84 associated with the handling of the animals during the ATR dosing procedure per se. In addition, the presence of a dose response for the elevated release of ACTH, CORT, and progesterone as well as the lack of habituation to repeated daily exposures to ATR for up to 28 days (Pruett et al., 2009) support the hypothesis that these effects are chemical dependent. Although no adverse clinical signs were observed in any of the animals, additional studies are needed to discern if the hormone changes are due to an undetected chemicalinduced malaise resulting from exposure or rather due to a direct effect on cellular mechanisms associated with the activation of the HPA axis. Although testicular steroid release may also play a role in the elevation of progesterone, the rapid changes in circulating progesterone observed in this study point to the adrenals as the primary source. Progesterone, a precursor in the synthesis of CORT, is released from the adrenals in response to ACTH (Deis et al., 1989; Resko, 1969) . Studies in our laboratory have shown that rapid increases in serum progesterone observed following the single dose of ATR are similar to those observed following an injection of ACTH. Serum CORT and progesterone in adult male rats were increased sixfold and 15.8-fold, respectively, compared with the controls (CORT, 77.6 ± 12.0 ng/ml and progesterone, 0.61 ± 0.04 ng/ml, n ¼ 10) when measured 2 h post-dosing with ACTH (10 lg/sc per rat). Comparable increases in serum CORT and progesterone were also observed in castrated male rats following ACTH injection. In addition, the observation that doseresponsive increases in progesterone occur in both castrated and intact male rats following three daily doses of ATR (Lowest observed effect level 50 mg/kg/3 days, oral; Modic, 2004) support the hypothesis that the elevated progesterone is of adrenal origin.
While plasma concentrations were measured for a limited number of animals, the analytical chemistry data provide insight as to which metabolites affect the release of ACTH and adrenal steroids. In rodents, ATR undergoes Phase Ibiotransformation to yield chlorinated N-dealkylation products, DIA, DEA, and DACT (Fig. 1) , and to a lesser extent Phase II-biotransformation by glutathione-S-transferase (Adams et al., 1990) . The profile of plasma concentrations following a single dose of ATR demonstrated that the parent compound was detectable within 5 min post-dosing and remained constant throughout the 180-min observation period, while the metabolites, DEA, DIA, and DACT, continued to increase with postdosing time. In contrast, single doses of DIA, DEA, or DACT yielded substantially higher initial plasma concentrations of each metabolite, and the concentrations were dose responsive within each post-dosing time point. These data support the physiologically based pharmacokinetic (PBPK) model for the oral absorption and oxidative metabolism of ATR in the female rat as proposed by McMullin et al. (2007) . In addition, data from this study are in agreement with previous reports that ATR is rapidly metabolized in rats and mice with DACT being the most persistent and abundant metabolite in the plasma following a single dose. While the plasma concentrations in this study are comparable with those reported for the rat by McMullin et al. (2003 McMullin et al. ( , 2007 and Brzezicki et al. (2003) , much greater quantitative differences were noted between these data and those reported for the mouse by Ross and Filipov (2006) and Ross et al. (2009) . Thus, differences among all these studies may be a reflection of the use of different species, doses, solvents for administration of the chlorotriazines, as well as different analytical methods. Finally, the plasma concentrations reported in this study clearly demonstrate that oral doses of DIA, DEA, or DACT that are equimolar to ATR do not produce comparable plasma levels in the male rat. Thus, comparisons of the relative potency of the test chemicals based solely upon an equimolar dosing regimen as opposed to the actual dose measured in plasma should be made with caution. 
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It is puzzling that although a clear dose-response relationship was evident for the hormone end points evaluated in this study, no dose response was observed for the plasma concentrations of ATR or its metabolites following a single dose of the parent compound. To our knowledge, no dose-response data for ATR and metabolite plasma concentrations in rats have been reported for the doses and time course used in this study. However, Ross et al. (2009) have shown dose-responsive plasma concentrations of ATR, DEA, DIA, and DACT as early as 30 min post-dosing in mice that received single doses of ATR ranging from 5 to 250 mg/kg. Certainly, more analytical data, including tissue concentrations, are needed to fully ascertain the disposition of ATR and metabolites within the first 3 h post-dosing. Nevertheless, the plasma concentrations reported here show the presence of ATR, DIA, DEA, and DACT as early as 5 min post-dosing with a clear increase in the metabolites, but not ATR, during the sampling period.
In 2006, the U.S. EPA completed a cumulative risk assessment for triazine pesticides, including ATR, PRO, SIM, and common metabolites, DIA, DEA, and DACT (U.S. EPA, 2006) . The Agency chose this group of pesticides based upon a common neuroendocrine mode of action (MOA) resulting in the disruption of the HPG axis in rats by inhibiting the release of LH and concluded that with the mitigation measures in the individual ATR and SIM risk assessment decisions, no additional regulations were needed for cumulative risks (U.S. EPA, 2006) . Data presented here confirm that the majority of these chlorotriazines also have a common effect on the HPA axis. In addition, this study supports the hypothesis that ATR, SIM, and PRO may alter the neuroendocrine regulation of both the HPG and the HPA axes. Whether or not there is a common mode or mechanism of action underlying these neuroendocrine changes remains to be determined. It is plausible that chlorotriazines and their metabolites can act at the level of the hypothalamus to modify the release of both GnRH and corticotrophin-releasing hormone thus altering LH and ACTH, respectively. It is also possible that chemical-induced changes in pituitary-adrenal hormone secretion result in subsequent changes in the hypothalamic regulation of pituitary-gonadal activity. Further research is needed to discern the MOA for the effects on both the HPA and the HPG axes. The extent to which continued exposure to the chlorotriazines will impact the HPA axis, and the role that such changes may contribute to the previously reported ATR-related adverse effects on the reproductive system remain to be determined.
